Test Focus Of Tariff Conversations Shifts To Stability, AdvaMed Says - Clone
AdvaMed president Scott Whitaker said the group is focused on the need for tariff stability in conversations with the Trump administration. The organization remains optimistic about other policy areas. New chairman and ResMed CEO Mick Farrell laid out his five priorities.
Stay ahead of every shift in generics and biosimilars.
